BI

Bio-Gate AGXETRA Bio-Gate Stock Report

Last reporting period 31 Dec, 2023

Updated 19 Sep, 2024

Last price

Market cap $B

0.019

Micro

Exchange

XETR - Xetra

BIG1.DE Stock Analysis

BI

Uncovered

Bio-Gate AG is uncovered by Eyestock quantitative analysis.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

3/100

Low score

Market cap $B

0.019

Dividend yield

Shares outstanding

7.639 B

Bio-Gate AG engages in the development and production of technologies and solutions for health and hygiene, primarily used in orthopedics, traumatology, and vascular surgery. The company is headquartered in Nuremberg, Bayern and currently employs 36 full-time employees. The company went IPO on 2006-04-05. The firm employs silver technology to endow materials and products with antimicrobial properties, and specializes in plasmacoating, spray, additives and textile solutions, among others. The company produces medical technology products, as well as technologies to refine cosmetics, consumer goods and industrial products. Its products are applied in the area of implants, skin care, cosmetics, orthopedics, industrial applications, consumer goods, would care, textiles and dental products. The firm incorporates silver particles into cosmetics, paints, veneers or plastics, or involves coating of final products, such as implants or wound dressings, with a silver-containing functional layer.

View Section: Eyestock Rating